Guidance regarding COVID-19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group

Lisanne C. Verbruggen, Yuehan Wang, Saro H. Armenian, Matthew J. Ehrhardt, Helena J. H. van der Pal, Elvira C. van Dalen, Jorrit W. van As, Edit Bardi, Katja Baust, Claire Berger, Elio Castagnola, Katie A. Devine, Judith Gebauer, Jordan Gilleland Marchak, Adam W. Glaser, Andreas H. Groll, Gabrielle M. Haeusler, Jaap den Hartogh, Riccardo Haupt, Lars HjorthMiho Kato, Tomáš Kepák, Maria M. W. Koopman, Thorsten Langer, Miho Maeda, Gisela Michel, Monica Muraca, Paul C. Nathan, Selina R. van den Oever, Vesna Pavasovic, Satomi Sato, Fiona Schulte, Lillian Sung, Wim Tissing, Anne Uyttebroeck, Renée L. Mulder, Claudia Kuehni, Roderick Skinner, Melissa M. Hudson, Leontien C. M. Kremer

Research output: Contribution to journalArticleAcademicpeer-review

22 Citations (Scopus)

Abstract

Childhood, adolescent, and young adult (CAYA) cancer survivors may be at risk for a severe course of COVID-19. Little is known about the clinical course of COVID-19 in CAYA cancer survivors, or if additional preventive measures are warranted. We established a working group within the International Late Effects of Childhood Cancer Guideline Harmonization Group (IGHG) to summarize existing evidence and worldwide recommendations regarding evidence about factors/conditions associated with risk for a severe course of COVID-19 in CAYA cancer survivors, and to develop a consensus statement to provide guidance for healthcare practitioners and CAYA cancer survivors regarding COVID-19.
Original languageEnglish
Article numbere28702
JournalPediatric blood & cancer
Volume67
Issue number12
Early online date2020
DOIs
Publication statusPublished - 1 Dec 2020

Keywords

  • COVID-19
  • childhood adolescent and young adult (CAYA) cancer survivors
  • late effects of cancer treatment

Cite this